[CBAY] CymaBay Therapeutics Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 39.37 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.79 Change: 0.01 (0.56%)
Ext. hours: Change: 0 (0%)

chart CBAY

Refresh chart

Strongest Trends Summary For CBAY

CBAY is in the long-term up 376% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: There is no Profile data available for CBAY.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding22.37 M EPS-1.05 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E-4.74
P/E To EPS Growth P/S P/BV2.16 Price/Cash Per Share1.2
Price/Free Cash Flow ROA-69.63% ROE-132.38% ROI-114.8%
Current Ratio2.52 Quick Ratio Long Term Debt/Equity0.13 Debt Ratio0.75
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.32 M Cash From Investing Activities1.1 M Cash From Operating Activities-6.16 M Gross Profit
Net Profit-2.33 M Operating Profit-6.78 M Total Assets34.73 M Total Current Assets34.49 M
Total Current Liabilities13.66 M Total Debt4.19 M Total Liabilities16.46 M Total Revenue
Technical Data
High 52 week15.16 Low 52 week8.43 Last close12.62 Last change-2.77%
RSI41.4 Average true range0.67 Beta1.16 Volume47.44 K
Simple moving average 20 days-1.24% Simple moving average 50 days-1.88% Simple moving average 200 days3.93%
Performance Data
Performance Week-2.92% Performance Month4.21% Performance Quart26.83% Performance Half3.78%
Performance Year3.02% Performance Year-to-date21.11% Volatility daily2.65% Volatility weekly5.94%
Volatility monthly12.16% Volatility yearly42.14% Relative Volume216.06% Average Volume735.65 K
New High New Low

News

2020-05-26 18:12:35 | Is CymaBay’s Seladelpar Back in the Saddle? 5-Star Analyst Weighs In

2020-05-21 07:21:00 | Will Good News Boost This Small-Cap Drug Company's Stock Even Higher?

2020-05-15 08:29:12 | Is CymaBay Therapeutics CBAY Stock a Solid Choice Right Now?

2020-05-13 09:37:01 | Do Options Traders Know Something About CymaBay Therapeutics CBAY Stock We Don't?

2020-05-13 08:18:56 | CymaBay CBAY Stock Is up 127% in a Day. How Much Higher Can It Go?

2020-05-12 15:20:55 | Edited Transcript of CBAY earnings conference call or presentation 11-May-20 8:30pm GMT

2020-05-12 10:34:46 | A Look Into CymaBay Therapeutics Price Over Earnings

2020-05-12 09:45:00 | CymaBay Therapeutics' stock more than doubles amid hopes FDA will lift hold on NASH treatment

2020-05-12 09:45:00 | CymaBay Therapeutics' stock more than doubles amid hopes FDA will lift hold on NASH treatment

2020-05-12 08:06:36 | The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings

2020-05-12 02:20:05 | CymaBay Doubles After-Hours On Positive NASH Trial Update

2020-05-12 02:00:58 | CymaBay Therapeutics Inc CBAY Q1 2020 Earnings Call Transcript

2020-05-11 16:01:10 | CymaBay Reports First Quarter 2020 Financial Results and Provides Corporate Update

2020-05-04 16:43:56 | CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11

2020-04-01 23:12:46 | Edited Transcript of CBAY earnings conference call or presentation 12-Mar-20 8:30pm GMT

2020-03-20 10:44:02 | Generic Drugs Industry's Prospects Uncertain Amid Coronavirus

2020-03-20 06:30:42 | We're Keeping An Eye On CymaBay Therapeutics's NASDAQ:CBAY Cash Burn Rate

2020-03-13 17:29:00 | CymaBay Therapeutics Comments on Engine Capital Director Nominations

2020-03-12 16:01:10 | CymaBay Reports Fourth Quarter and Fiscal Year End 2019 Financial Results and Provides Corporate Update

2020-03-12 14:30:00 | CymaBay Therapeutics, Inc. to Host Earnings Call

2020-03-11 19:00:00 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges CymaBay Therapeutics CBAY Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigation Possible Securities Fraud

2020-03-10 12:15:00 | IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-10 08:44:12 | Is the Options Market Predicting a Spike in CymaBay Therapeutics CBAY Stock?

2020-03-09 19:51:10 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics CBAY Investors Who Have Suffered Losses to Contact its Attorneys: Investigation Into Possible Securities Fraud Ongoing

2020-03-09 11:40:00 | SHAREHOLDER NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-09 10:57:07 | ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against CymaBay Therapeutics, Inc. – CBAY

2020-03-06 10:49:00 | 4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens

2020-03-05 19:00:00 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds CymaBay Therapeutics CBAY Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

2020-03-05 16:01:10 | CymaBay Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 12

2020-03-05 13:30:00 | SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-04 18:09:00 | CYMABAY ALERT: Bragar Eagel & Squire, P.C. Is Investigating CymaBay Therapeutics, Inc. on Behalf of Stockholders and Encourages Investors to Contact the Firm

2020-03-03 15:12:00 | INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-03 12:27:43 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics CBAY Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

2020-03-03 11:00:00 | CBAY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of CymaBay Therapeutics, Inc. and Encourages Investors to Contact the Firm

2020-03-03 01:10:00 | IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-02 18:50:00 | CBAY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of CymaBay Therapeutics, Inc. and Encourages Investors to Contact the Firm

2020-03-02 18:07:00 | INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CymaBay Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

2020-03-02 16:15:00 | EQUITY ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against CymaBay Therapeutics, Inc. – CBAY

2020-03-02 08:09:07 | CymaBay Therapeutics Investigated for Possible Securities Fraud by Block & Leviton

2020-02-28 21:52:00 | HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics CBAY Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud

2020-02-05 11:52:05 | Steven Cohen Renews His Interest in Verastem

2020-01-29 16:15:10 | CymaBay Publishes Shareholder Letter

2020-01-10 09:21:02 | CymaBay Therapeutics Enters Oversold Territory

2019-12-31 11:48:16 | These Falling Knives May Be Worth Catching

2019-12-17 10:31:03 | Gilead GILD Announces Top-Line Results From NASH Study

2019-12-10 15:36:11 | Genfit Hopes to Buck the Odds With NASH Drug

2019-12-09 06:09:02 | Should You Take Comfort From Insider Transactions At CymaBay Therapeutics, Inc. NASDAQ:CBAY?

2019-12-08 19:09:46 | Is CymaBay Therapeutics Inc CBAY Going To Burn These Hedge Funds ?

2019-11-29 11:24:04 | The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx

2019-11-29 08:41:01 | NASH Scorecard Year to Date: The Winners and the Losers